FDA Vs. The Three-Second Rule
This article was originally published in RPM Report
FDA’s crackdown on Indian manufacturing facilities continues four years after FDASIA boosted overseas inspection reports. The Warning Letters continue to paint an unflattering picture of practices at some sites.
Register for our free email digests: